TY  - JOUR
T1  - The use of sublingual nifedipine: A continuing concern
AU  - Messerli FH, Grossman E
Y1  - 1999/10/01
N1  - 10.1001/archinte.159.19.2259
JO  - Archives of Internal Medicine
SP  - 2259
EP  - 2260
VL  - 159
IS  - 19
N2  - 
IN 1995, the Cardiorenal Advisory Committee of the Food and Drug Administration, after a lengthy deliberation, unanimously decided that sublingual nifedipine should not officially be approved for the treatment of hypertensive emergencies. Despite this decision and despite authoritative voices1- 4 warning against this practice, the use of short-acting nifedipine for what was perceived as hypertensive emergencies remained widespread in the United States and all over the globe.

SN  - 0003-9926
M3  - doi: 10.1001/archinte.159.19.2259
UR  - http://dx.doi.org/10.1001/archinte.159.19.2259
ER  -